New Durolane Agreement in Russia

Bioventus selected MEDSERVICE to distribute DUROLANE® single-injection joint fluid in Russia. Specifically, MEDSERVICE will offer a 3ml dose indicated to treat mild to moderate knee or hip osteoarthritis (OA), and DUROLANE SJ in a 1ml dose for mild to moderate OA pain in the ankle, elbow, wrist, fingers and toes.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us